1. Vinagre J, Almeida A, Pópulo H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Simões M, Lima J, Máximo V, Soares P

Frequency of TERT promoter mutations in human cancers. Nature communications 4: 2185, 2013.  [Article] 

 doi: 10.1038/ncomms3185 PMID: 23887589.

 

2. Pertega-Gomes N, Felisbino S, Massie CE, Vizcaino JR, Coelho R, Sandi C, Simoes-Sousa S, Jurmeister S, Ramos-Montoya A, Asim M, Tran M, Oliveira E, Lobo da Cunha A, Maximo V, Baltazar F, Neal DE, Fryer LG

A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy. The Journal of pathology 236: 517-30, 2015.  [Article] 

 doi: 10.1002/path.4547 PMID: 25875424.

 

3. Coelho R, Marcos-Silva L, Mendes N, Pereira D, Brito C, Jacob F, Steentoft C, Mandel U, Clausen H, David L, Ricardo S

Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours. International journal of molecular sciences 19: ., 2018.  [Article] 

 doi: 10.3390/ijms19072045 PMID: 30011875.

 

4. Pereira SS, Máximo V, Coelho R, Batista R, Soares P, Guerreiro SG, Sobrinho-Simões M, Monteiro MP, Pignatelli D

Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas. Journal of cellular biochemistry 118: 2064-2071, 2017.  [Article] 

 doi: 10.1002/jcb.25811 PMID: 27886397.

 

5. Ricardo S, Marcos-Silva L, Valente C, Coelho R, Gomes R, David L

Mucins MUC16 and MUC1 are major carriers of SLe(a) and SLe(x) in borderline and malignant serous ovarian tumors. Virchows Archiv : an international journal of pathology 468: 715-22, 2016.  [Article] 

 doi: 10.1007/s00428-016-1929-6 PMID: 27003157.

 

6. Coelho R, Marcos-Silva L, Ricardo S, Ponte F, Costa A, Lopes JM, David L

Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment. Expert review of anticancer therapy 18: 177-186, 2018.  [Review] 

 doi: 10.1080/14737140.2018.1418326 PMID: 29241375.

 

7. Lau E, Freitas P, Costa J, Batista R, Máximo V, Coelho R, Matos-Lima L, Eloy C, Carvalho D

Loss of mitochondrial SDHB expression: what is its role in diffuse thyroid lipomatosis? Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 47: 165-7, 2015.  [Article] 

 doi: 10.1055/s-0034-1398559 PMID: 25679879.